Papers
24
Total Citations
639
H-Index
15
About
Greg Shaw is a urological surgeon and clinical researcher whose work has significantly advanced the field of minimally invasive prostate cancer surgery, with a particular focus on robot-assisted radical prostatectomy (RARP). His research spans surgical oncology, functional outcomes, and intraoperative decision-making, making him a pivotal figure in refining robotic surgical techniques. Shaw's landmark 2013 multinational study examining positive surgical margin rates across over 22,000 patients (151 citations) established critical benchmarks comparing open, laparoscopic, and robotic approaches. He has been instrumental in developing and validating the NeuroSAFE technique — a real-time frozen section analysis that enables surgeons to more accurately spare the neurovascular bundles during prostatectomy, thereby preserving erectile function and urinary continence. His NeuroSAFE PROOF randomised controlled trial represents a milestone achievement, progressing from feasibility studies to a fully-powered phase 3 trial. Shaw has also contributed meaningfully to understanding robotic surgery learning curves, optimising continence recovery strategies, and evaluating salvage prostatectomy outcomes. Collectively, his work — accumulating nearly 600 citations — has directly influenced how surgeons balance cancer control with quality-of-life outcomes for men with localised prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2Learning Curves for Robotic Surgery: a Review of the Recent Literature71 citations · 2017
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10